Movatterモバイル変換

[0]ホーム
URL:

GB0421438D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0421438D0
GB0421438D0GB0421438AGB0421438AGB0421438D0GB 0421438 D0GB0421438 D0GB 0421438D0GB 0421438 AGB0421438 AGB 0421438AGB 0421438 AGB0421438 AGB 0421438AGB 0421438 D0GB0421438 D0GB 0421438D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0421438A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca ABfiledCriticalAstraZeneca AB
Priority to GB0421438ApriorityCriticalpatent/GB0421438D0/en
Publication of GB0421438D0publicationCriticalpatent/GB0421438D0/en
Priority to EP05786268Aprioritypatent/EP1804802A2/en
Priority to MX2007003505Aprioritypatent/MX2007003505A/en
Priority to CA002578956Aprioritypatent/CA2578956A1/en
Priority to JP2007532963Aprioritypatent/JP2008514577A/en
Priority to PCT/GB2005/003673prioritypatent/WO2006035204A2/en
Priority to KR1020077009369Aprioritypatent/KR20070072543A/en
Priority to CN2005800325888Aprioritypatent/CN101027059B/en
Priority to US11/663,913prioritypatent/US20080119479A1/en
Priority to BRPI0516052-9Aprioritypatent/BRPI0516052A/en
Priority to AU2005288737Aprioritypatent/AU2005288737B2/en
Priority to IL181609Aprioritypatent/IL181609A0/en
Priority to NO20071428Aprioritypatent/NO20071428L/en
Priority to ZA200702227Aprioritypatent/ZA200702227B/en
Priority to US12/479,131prioritypatent/US20100069398A1/en
Ceasedlegal-statusCriticalCurrent

Links

GB0421438A2004-04-012004-09-27Combination therapyCeasedGB0421438D0 (en)

Priority Applications (15)

Application NumberPriority DateFiling DateTitle
GB0421438AGB0421438D0 (en)2004-09-272004-09-27Combination therapy
AU2005288737AAU2005288737B2 (en)2004-09-272005-09-23Combination comprising ZD6474 and imatinib
KR1020077009369AKR20070072543A (en)2004-09-272005-09-23 Combination method including wd6474 and imatinib
US11/663,913US20080119479A1 (en)2004-04-012005-09-23Combination Comprising Zd6474 And Imatinib
CA002578956ACA2578956A1 (en)2004-09-272005-09-23Combination comprising zd6474 and an imatinib
JP2007532963AJP2008514577A (en)2004-09-272005-09-23 A combination comprising ZD6474 and imatinib
PCT/GB2005/003673WO2006035204A2 (en)2004-09-272005-09-23Combination comprising zd6474 and an imatinib
EP05786268AEP1804802A2 (en)2004-09-272005-09-23Combination comprising zd6474 and an imatinib
CN2005800325888ACN101027059B (en)2004-09-272005-09-23 Composition comprising ZD6474 and imatinib and pharmaceutical use thereof
MX2007003505AMX2007003505A (en)2004-09-272005-09-23Combination comprising zd6474 and an imatinib.
BRPI0516052-9ABRPI0516052A (en)2004-09-272005-09-23 use of zd6474 or a pharmaceutically acceptable salt thereof and imatinib, pharmaceutical composition, kit, and method for producing an antiangiogenic effect and / or reducing vascular permeability in a warm-blooded animal
IL181609AIL181609A0 (en)2004-09-272007-02-27Combination comprising zd6474 and imatinib
NO20071428ANO20071428L (en)2004-09-272007-03-16 Combination containing ZD6474 and Imatinib
ZA200702227AZA200702227B (en)2004-09-272007-03-16Combination comprising ZD6474 and imatinib
US12/479,131US20100069398A1 (en)2004-09-272009-06-05Combination therapy

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB0421438AGB0421438D0 (en)2004-09-272004-09-27Combination therapy

Publications (1)

Publication NumberPublication Date
GB0421438D0true GB0421438D0 (en)2004-10-27

Family

ID=33397325

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB0421438ACeasedGB0421438D0 (en)2004-04-012004-09-27Combination therapy

Country Status (3)

CountryLink
CN (1)CN101027059B (en)
GB (1)GB0421438D0 (en)
ZA (1)ZA200702227B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
KR101386697B1 (en)*2012-06-182014-04-18아주대학교산학협력단Composition for preventing or treating vascular permeability disease comprising imatinib or pharmaceutically acceptable salts thereof as active ingredient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE60039206D1 (en)*1999-11-052008-07-24Astrazeneca Ab New quinazoline derivatives

Also Published As

Publication numberPublication date
ZA200702227B (en)2008-10-29
CN101027059B (en)2011-07-27
CN101027059A (en)2007-08-29

Similar Documents

PublicationPublication DateTitle
SI2601972T1 (en)Non-lithotripsic kidney-stone therapy
IL177155A0 (en)Therapeutic combinations
GB0403780D0 (en)Therapeutic agents
GB0428180D0 (en)Combination therapy
GB0417481D0 (en)Combination therapy
ZA200709627B (en)Combination therapy
GB0424339D0 (en)Combination therapy
GB0504206D0 (en)Combination therapy
GB0509052D0 (en)Combination therapy
GB0417558D0 (en)Novel combination therapy
GB0518720D0 (en)Therapeutic combination
GB0400193D0 (en)Therapeutic agents
GB0421436D0 (en)Combination therapy
GB0421438D0 (en)Combination therapy
GB0400196D0 (en)Therapeutic agents
GB0407755D0 (en)Combination therapy
GB0406450D0 (en)Combination therapy
GB0424638D0 (en)Combination therapy
GB0407753D0 (en)Combination therapy
GB0406546D0 (en)Combination therapy
GB0402918D0 (en)Therapeutic agents
GB0403779D0 (en)Therapeutic agents
GB0506726D0 (en)Combination therapy
GB0526132D0 (en)Combination Therapy
GB0506725D0 (en)Combination therapy

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)
[8]ページ先頭
©2009-2025 Movatter.jp